Skip to main content

Breadcrumb

  1. Home

Use of Receptor Occupancy Assays on cells from Peripheral Blood as a Surrogate Model of the Tumor Microenvironment

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Use of Receptor Occupancy Assays on cells from Peripheral Blood as a Surrogate Model of the Tumor Microenvironment

Ubiquitin ligases implicated as predictive biomarkers for poor outcome to immunotherapy in melanoma patients

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Ubiquitin ligases implicated as predictive biomarkers for poor outcome to immunotherapy in melanoma patients

Spatial interrogation of tertiary lymphoid structures (TLS) in colorectal carcinoma (CRC) tumor microenvironment (TME) using the MultiOmyxTM assay

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Spatial interrogation of tertiary lymphoid structures (TLS) in colorectal carcinoma (CRC) tumor microenvironment (TME) using the MultiOmyxTM assay

Pattern of PIK3CA co-alterations in endometrial cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Pattern of PIK3CA co-alterations in endometrial cancer

Obesity-Induced Changes in the Tumor Microenvironment Impact the Response to Chemotherapy and Overall Ovarian Cancer Metastatic Success

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Obesity-Induced Changes in the Tumor Microenvironment Impact the Response to Chemotherapy and Overall Ovarian Cancer Metastatic Success

Molecular profiling of RUNX1/RUNT domain in myeloid disorders

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Molecular profiling of RUNX1/RUNT domain in myeloid disorders

Minimal Residual Disease (MRD) As A Predictive Biomarker/Endpoint for Novel Drug Development

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Minimal Residual Disease (MRD) As A Predictive Biomarker/Endpoint for Novel Drug Development

Dual approach using proteomics and multiplexed immunofluorescence for the detection of markers predictive for immunotherapy in melanoma patients

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Dual approach using proteomics and multiplexed immunofluorescence for the detection of markers predictive for immunotherapy in melanoma patients

Custom PhenoImager™ fluorescent multiplex IHC panel identifies mature tertiary lymphoid structures in colorectal cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Custom PhenoImager™ fluorescent multiplex IHC panel identifies mature tertiary lymphoid structures in colorectal cancer

Comprehensive characterization of the biology of inflammatory bowel disease-associated colorectal cancer using the GeoMx® Digital Spatial Profiler (DSP)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Comprehensive characterization of the biology of inflammatory bowel disease-associated colorectal cancer using the GeoMx® Digital Spatial Profiler (DSP)

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • …
  • Next page Next
  • Last page Last
Subscribe to